Abstract:The purpose of this study was to evaluate the relationship between hypoxia-inducible factor-1α (HIF-1α) protein expression in hepatocellular carcinoma (HCC), and responses of abdominal metastatic lymph nodes (LNs) from HCC patients treated with external beam radiotherapy (EBRT). HIF-1α immunohistochemical staining was performed on tissue microarrays (TMAs) of primary HCC specimens from 69 HCC patients with abdominal LN metastases. All patients received abdominal metastatic LN EBRT at the Department of Radiation Oncology at Zhongshan Hospital. A receiver-operating characteristic (ROC)-based approach and logistical regression analysis were used to determine the predictive value of HIF-1α expression in primary tumors with HCC metastatic LN EBRT response. Kaplan–Meier curves and log-rank tests were used to analyze patient survival. Cox proportional hazards regression model was used to analyze independent prognostic factors. HIF-1α expression was correlated with blood hemoglobin (Hb: r = −0.280, P = 0.020), response of abdominal metastatic LNs to EBRT ( r = 0.286, P = 0.017), locoregional recurrence ( r = 0.278, P = 0.021), and cancer-specific deaths ( r = 0.298, P = 0.013). HIF-1α expression was predictive of EBRT response of metastatic LNs [area under the curve (AUC): 0.646; 95% confidence interval (CI): 0.499–0.793; P = 0.047], locoregional recurrence (AUC: 0.657; 95% CI: 0.509–0.805; P = 0.049) and cancer-specific deaths (AUC: 0.671; 95% CI: 0.531–0.812; P = 0.035). Patients with tumors exhibiting high HIF-1α expression had significantly poorer overall survival (OS) than those with low tumor expression of HIF-1α ( P = 0.016). Multivariate analysis showed that Hb ( P = 0.035), vascular invasion ( P = 0.026), Child-Pugh score ( P < 0.001), intrahepatic tumor control ( P < 0.001), and HIF-1α ( P = 0.020) were independent prognosis factors for OS of HCC patients after receiving abdominal metastatic LN EBRT. HIF-1α expression in primary HCCs was associated with EBRT response of abdominal metastatic LNs and poor prognosis.

Response of Hypoxia-Response Element in Human Liver Cancer Cells to Different Microenvironments

Hypoxia Induced ANKRD37 Promotes Angiogenesis and Reprograms Glucose Metabolism in Hepatocellular Carcinoma Following Liver Transplantation.

[The Inhibition of VEGF Expression Induced by HIF-1alpha RNA Interference].

Expression of Hypoxia-Inducible Factor 1α and Vascular Endothelial Growth Factor in Hepatocellular Carcinoma: Impact on Neovascularization and Survival

Identification of Genes Involved in Adaptive Response to Hypoxia and Their Expression Attenuations by Gene Silencing of HIF-1α in A549 Lung Cancer Cells

Effects of hypoxia on the expressions of hypoxia-inducible factor-1 alpha and miR-210 in hepatocellular carcinoma HepG2 cells

Expression of Heme Oxygenase-1 and Its Effect on VEGF in Human Lung Cancer Cells

Expression of HIF-1α and VEGF in Hepatocellular Carcinoma and Correlation with Tumor Angiogenesis

Effects of HIF-1a and VEGF on the microenvironment of primary hepatocellular carcinoma

Hypoxic Response Elements and Tet-On Advanced Double-Controlled Systems Regulate Hvegf165 and Angiopoietin-1 Gene Expression in Vitro

In Vivo Real-Time Monitoring of the Development of Hypoxia and Angiogenesis in Cervical Cancer

Expressions and Clinical Significance of HIF-1α and Multidrug Resistance Genes in Human Colorectal Adenocarcinoma

Effect of Normoxic Acidosis on HIF-1α Protein Expression and Activity in Human Liver Cancer Cell Line HepG2

Regulation Of Hypoxia Inducible Factor-1 Alpha Expression By The Alteration Of Redox Status In Hepg2 Cells

Effect of Angiopoietin2,hypoxia Inducible Factor-1Α and Vascular Endothelial Growth Factor on Angiogenesis in Human Hepatocellular Carcinoma

Intermittent Hypoxia Alleviates Increased VEGF and Pro-Angiogenic Potential in Liver Cancer Cells.

Effects of Tumor Microenviromental Factors on Vegf Expression

The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome

Expression characteristics of hypoxia-inducible factor-1α and its clinical values in diagnosis and prognosis of hepatocellular carcinoma.

Expressions of Hypoxia-Inducible Factors and Its Related Proteins in Hepatoblastoma

Relationship between the expression of CD133, HIF-1α, VEGF and the proliferation and apoptosis in hypoxic human prostate cancer cells